Intestine colonizing lactobacilli
AssigneeProbi AB
InventorsStig Bengmark, Siv Ahrne, Goran Molin, Bengt Jeppson
Life of this patent
Estimating the term…
Abstract
A process for isolation of a strain of Lactobacillus having the ability of being established on human intestinal mucosa in vivo and being able to remain therein after oral administration for at least 10 days after the completion of the administration. By the process the new strains L. plantarum 299 (DSM 6595) and L. casei ssp. rhamnosus 271 (DSM 6594) have been isolated, which are useful for the prophylaxis or treatment of bacterial infections, especially in the form of a fermented nutrient composition.
Claims3
A composition for prophylaxis or treatment of infections of the gastro-intestinal tract, comprising a conventional carrier and a strain of Lactobacillus having the ability to colonize human intestinal mucosa in vivo and having all the identifying characteristics of:
- Lactobacillus plantatum 299 DSM 6595, or
- Lactobacillus casei ssp rhamnosus 271 DSM 6594.
A method for prophylaxis or for the treatment of bacterial infections of the gastrointestinal tract, comprising administering a nutrient composition comprising a conventional carrier and a strain of Lactobacillus having the ability to colonize human intestinal mucosa in vivo and having all the identifying characteristics of:
- Lactobacillus plantatum 299 DSM 6595, or
- Lactobacillus casei ssp rhamnosus 271 DSM 6594.
Dependencies are inferred from the claim text.